Cell Viability Assays Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (Consumables, Instruments); Cell Type (Human Cells, Animal Cells, Microbial Cells); Application (Drug Discovery and Development, Basic Research, Stem Cell Research, Clinical and Diagnostic Applications, Other Applications); End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital and Diagnostic Laboratories, Other End Users)
Report Code: TIPRE00007417
| No. of Pages: 150
| Category: Medical Device
| Status: Upcoming
A cell viability assays is an assay to determine the ability of the organs, cell, or tissue to maintain or recover viability. Viability assay can assist by assisting mechanical motility, contraction, and others that are used during viability assessment. By using viability dues, the counting of a cell is performed that can offer viable cell percentage and proliferation rate.
MARKET DYNAMICS
The cell viability assays market is estimated to grow in the market as the funding and research activities are increasing its demand during the forecast period. Also, with the continuous focus on improving the cell-based therapeutics, the market is expecting to grow. However, the high cost of instruments for the cell viability market is restraining market growth. Moreover, the emerging new market in the industry has the opportunity to grow the market in the forecast period.
MARKET SCOPE
The "Cell Viability Assays Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in cell viability assays market with detailed market segmentation by product, cell type, application, end user and geography. The cell viability assays market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in cell viability assays market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The cell viability assays market is segmented on the basis of product, cell type, application and end user. Based on product the market is segmented as consumables and instruments. On the basis of cell type the market is categorized as human cells, animal cells and microbial cells. On the basis of application the market is categorized as drug discovery and development, basic research, stem cell research, clinical and diagnostic applications and other applications. On the basis of end user the market is categorized as pharmaceutical & biotechnology companies, academic & research institutes, hospital & diagnostic laboratories and other end users.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in cell viability assays market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell viability assays market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell viability assays market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell viability assays market in these regions.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the in cell viability assays market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in cell viability assays market are anticipated to have lucrative growth opportunities in the future with the rising demand for in cell viability assays market in the global market. Below mentioned is the list of few companies engaged in the Cell Viability Assays market.
The report also includes the profiles of key in cell viability assays market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Thermo Fisher Scientific
Merck KGaA
Bio-Rad Laboratories
GE Healthcare
Danaher Corporation
Becton, Dickinson and Company
Promega Corporation
Abcam PLC
Perkinelmer
Biotek Instruments
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 Cell Viability Assays Market - By Product 1.3.2 Cell Viability Assays Market - By Cell Type 1.3.3 Cell Viability Assays Market - By Application 1.3.4 Cell Viability Assays Market - By End User 1.3.5 Cell Viability Assays Market - By Region 1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL VIABILITY ASSAYS MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS
6. CELL VIABILITY ASSAYS MARKET - GLOBAL MARKET ANALYSIS 6.1. CELL VIABILITY ASSAYS - GLOBAL MARKET OVERVIEW 6.2. CELL VIABILITY ASSAYS - GLOBAL MARKET AND FORECAST TO 2028 6.3. MARKET POSITIONING/MARKET SHARE
7. CELL VIABILITY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT 7.1. OVERVIEW 7.2. PRODUCT MARKET FORECASTS AND ANALYSIS 7.3. CONSUMABLES 7.3.1. Overview 7.3.2. Consumables Market Forecast and Analysis 7.4. INSTRUMENTS 7.4.1. Overview 7.4.2. Instruments Market Forecast and Analysis 8. CELL VIABILITY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - CELL TYPE 8.1. OVERVIEW 8.2. CELL TYPE MARKET FORECASTS AND ANALYSIS 8.3. HUMAN CELLS 8.3.1. Overview 8.3.2. Human Cells Market Forecast and Analysis 8.4. ANIMAL CELLS 8.4.1. Overview 8.4.2. Animal Cells Market Forecast and Analysis 8.5. MICROBIAL CELLS 8.5.1. Overview 8.5.2. Microbial Cells Market Forecast and Analysis 9. CELL VIABILITY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION 9.1. OVERVIEW 9.2. APPLICATION MARKET FORECASTS AND ANALYSIS 9.3. DRUG DISCOVERY AND DEVELOPMENT 9.3.1. Overview 9.3.2. Drug Discovery and Development Market Forecast and Analysis 9.4. BASIC RESEARCH 9.4.1. Overview 9.4.2. Basic Research Market Forecast and Analysis 9.5. STEM CELL RESEARCH 9.5.1. Overview 9.5.2. Stem Cell Research Market Forecast and Analysis 9.6. CLINICAL AND DIAGNOSTIC APPLICATIONS 9.6.1. Overview 9.6.2. Clinical and Diagnostic Applications Market Forecast and Analysis 9.7. OTHER APPLICATIONS 9.7.1. Overview 9.7.2. Other Applications Market Forecast and Analysis 10. CELL VIABILITY ASSAYS MARKET - REVENUE AND FORECASTS TO 2028 - END USER 10.1. OVERVIEW 10.2. END USER MARKET FORECASTS AND ANALYSIS 10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 10.3.1. Overview 10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis 10.4. ACADEMIC AND RESEARCH INSTITUTES 10.4.1. Overview 10.4.2. Academic and Research Institutes Market Forecast and Analysis 10.5. HOSPITAL AND DIAGNOSTIC LABORATORIES 10.5.1. Overview 10.5.2. Hospital and Diagnostic Laboratories Market Forecast and Analysis 10.6. OTHER END USERS 10.6.1. Overview 10.6.2. Other End Users Market Forecast and Analysis 11. CELL VIABILITY ASSAYS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS 11.1. NORTH AMERICA 11.1.1 North America Cell Viability Assays Market Overview 11.1.2 North America Cell Viability Assays Market Forecasts and Analysis 11.1.3 North America Cell Viability Assays Market Forecasts and Analysis - By Product 11.1.4 North America Cell Viability Assays Market Forecasts and Analysis - By Cell Type 11.1.5 North America Cell Viability Assays Market Forecasts and Analysis - By Application 11.1.6 North America Cell Viability Assays Market Forecasts and Analysis - By End User 11.1.7 North America Cell Viability Assays Market Forecasts and Analysis - By Countries 11.1.7.1 United States Cell Viability Assays Market 11.1.7.1.1 United States Cell Viability Assays Market by Product 11.1.7.1.2 United States Cell Viability Assays Market by Cell Type 11.1.7.1.3 United States Cell Viability Assays Market by Application 11.1.7.1.4 United States Cell Viability Assays Market by End User 11.1.7.2 Canada Cell Viability Assays Market 11.1.7.2.1 Canada Cell Viability Assays Market by Product 11.1.7.2.2 Canada Cell Viability Assays Market by Cell Type 11.1.7.2.3 Canada Cell Viability Assays Market by Application 11.1.7.2.4 Canada Cell Viability Assays Market by End User 11.1.7.3 Mexico Cell Viability Assays Market 11.1.7.3.1 Mexico Cell Viability Assays Market by Product 11.1.7.3.2 Mexico Cell Viability Assays Market by Cell Type 11.1.7.3.3 Mexico Cell Viability Assays Market by Application 11.1.7.3.4 Mexico Cell Viability Assays Market by End User 11.2. EUROPE 11.2.1 Europe Cell Viability Assays Market Overview 11.2.2 Europe Cell Viability Assays Market Forecasts and Analysis 11.2.3 Europe Cell Viability Assays Market Forecasts and Analysis - By Product 11.2.4 Europe Cell Viability Assays Market Forecasts and Analysis - By Cell Type 11.2.5 Europe Cell Viability Assays Market Forecasts and Analysis - By Application 11.2.6 Europe Cell Viability Assays Market Forecasts and Analysis - By End User 11.2.7 Europe Cell Viability Assays Market Forecasts and Analysis - By Countries 11.2.7.1 Germany Cell Viability Assays Market 11.2.7.1.1 Germany Cell Viability Assays Market by Product 11.2.7.1.2 Germany Cell Viability Assays Market by Cell Type 11.2.7.1.3 Germany Cell Viability Assays Market by Application 11.2.7.1.4 Germany Cell Viability Assays Market by End User 11.2.7.2 France Cell Viability Assays Market 11.2.7.2.1 France Cell Viability Assays Market by Product 11.2.7.2.2 France Cell Viability Assays Market by Cell Type 11.2.7.2.3 France Cell Viability Assays Market by Application 11.2.7.2.4 France Cell Viability Assays Market by End User 11.2.7.3 Italy Cell Viability Assays Market 11.2.7.3.1 Italy Cell Viability Assays Market by Product 11.2.7.3.2 Italy Cell Viability Assays Market by Cell Type 11.2.7.3.3 Italy Cell Viability Assays Market by Application 11.2.7.3.4 Italy Cell Viability Assays Market by End User 11.2.7.4 Spain Cell Viability Assays Market 11.2.7.4.1 Spain Cell Viability Assays Market by Product 11.2.7.4.2 Spain Cell Viability Assays Market by Cell Type 11.2.7.4.3 Spain Cell Viability Assays Market by Application 11.2.7.4.4 Spain Cell Viability Assays Market by End User 11.2.7.5 United Kingdom Cell Viability Assays Market 11.2.7.5.1 United Kingdom Cell Viability Assays Market by Product 11.2.7.5.2 United Kingdom Cell Viability Assays Market by Cell Type 11.2.7.5.3 United Kingdom Cell Viability Assays Market by Application 11.2.7.5.4 United Kingdom Cell Viability Assays Market by End User 11.3. ASIA-PACIFIC 11.3.1 Asia-Pacific Cell Viability Assays Market Overview 11.3.2 Asia-Pacific Cell Viability Assays Market Forecasts and Analysis 11.3.3 Asia-Pacific Cell Viability Assays Market Forecasts and Analysis - By Product 11.3.4 Asia-Pacific Cell Viability Assays Market Forecasts and Analysis - By Cell Type 11.3.5 Asia-Pacific Cell Viability Assays Market Forecasts and Analysis - By Application 11.3.6 Asia-Pacific Cell Viability Assays Market Forecasts and Analysis - By End User 11.3.7 Asia-Pacific Cell Viability Assays Market Forecasts and Analysis - By Countries 11.3.7.1 Australia Cell Viability Assays Market 11.3.7.1.1 Australia Cell Viability Assays Market by Product 11.3.7.1.2 Australia Cell Viability Assays Market by Cell Type 11.3.7.1.3 Australia Cell Viability Assays Market by Application 11.3.7.1.4 Australia Cell Viability Assays Market by End User 11.3.7.2 China Cell Viability Assays Market 11.3.7.2.1 China Cell Viability Assays Market by Product 11.3.7.2.2 China Cell Viability Assays Market by Cell Type 11.3.7.2.3 China Cell Viability Assays Market by Application 11.3.7.2.4 China Cell Viability Assays Market by End User 11.3.7.3 India Cell Viability Assays Market 11.3.7.3.1 India Cell Viability Assays Market by Product 11.3.7.3.2 India Cell Viability Assays Market by Cell Type 11.3.7.3.3 India Cell Viability Assays Market by Application 11.3.7.3.4 India Cell Viability Assays Market by End User 11.3.7.4 Japan Cell Viability Assays Market 11.3.7.4.1 Japan Cell Viability Assays Market by Product 11.3.7.4.2 Japan Cell Viability Assays Market by Cell Type 11.3.7.4.3 Japan Cell Viability Assays Market by Application 11.3.7.4.4 Japan Cell Viability Assays Market by End User 11.3.7.5 South Korea Cell Viability Assays Market 11.3.7.5.1 South Korea Cell Viability Assays Market by Product 11.3.7.5.2 South Korea Cell Viability Assays Market by Cell Type 11.3.7.5.3 South Korea Cell Viability Assays Market by Application 11.3.7.5.4 South Korea Cell Viability Assays Market by End User 11.4. MIDDLE EAST AND AFRICA 11.4.1 Middle East and Africa Cell Viability Assays Market Overview 11.4.2 Middle East and Africa Cell Viability Assays Market Forecasts and Analysis 11.4.3 Middle East and Africa Cell Viability Assays Market Forecasts and Analysis - By Product 11.4.4 Middle East and Africa Cell Viability Assays Market Forecasts and Analysis - By Cell Type 11.4.5 Middle East and Africa Cell Viability Assays Market Forecasts and Analysis - By Application 11.4.6 Middle East and Africa Cell Viability Assays Market Forecasts and Analysis - By End User 11.4.7 Middle East and Africa Cell Viability Assays Market Forecasts and Analysis - By Countries 11.4.7.1 South Africa Cell Viability Assays Market 11.4.7.1.1 South Africa Cell Viability Assays Market by Product 11.4.7.1.2 South Africa Cell Viability Assays Market by Cell Type 11.4.7.1.3 South Africa Cell Viability Assays Market by Application 11.4.7.1.4 South Africa Cell Viability Assays Market by End User 11.4.7.2 Saudi Arabia Cell Viability Assays Market 11.4.7.2.1 Saudi Arabia Cell Viability Assays Market by Product 11.4.7.2.2 Saudi Arabia Cell Viability Assays Market by Cell Type 11.4.7.2.3 Saudi Arabia Cell Viability Assays Market by Application 11.4.7.2.4 Saudi Arabia Cell Viability Assays Market by End User 11.4.7.3 U.A.E Cell Viability Assays Market 11.4.7.3.1 U.A.E Cell Viability Assays Market by Product 11.4.7.3.2 U.A.E Cell Viability Assays Market by Cell Type 11.4.7.3.3 U.A.E Cell Viability Assays Market by Application 11.4.7.3.4 U.A.E Cell Viability Assays Market by End User 11.5. SOUTH AND CENTRAL AMERICA 11.5.1 South and Central America Cell Viability Assays Market Overview 11.5.2 South and Central America Cell Viability Assays Market Forecasts and Analysis 11.5.3 South and Central America Cell Viability Assays Market Forecasts and Analysis - By Product 11.5.4 South and Central America Cell Viability Assays Market Forecasts and Analysis - By Cell Type 11.5.5 South and Central America Cell Viability Assays Market Forecasts and Analysis - By Application 11.5.6 South and Central America Cell Viability Assays Market Forecasts and Analysis - By End User 11.5.7 South and Central America Cell Viability Assays Market Forecasts and Analysis - By Countries 11.5.7.1 Brazil Cell Viability Assays Market 11.5.7.1.1 Brazil Cell Viability Assays Market by Product 11.5.7.1.2 Brazil Cell Viability Assays Market by Cell Type 11.5.7.1.3 Brazil Cell Viability Assays Market by Application 11.5.7.1.4 Brazil Cell Viability Assays Market by End User 11.5.7.2 Argentina Cell Viability Assays Market 11.5.7.2.1 Argentina Cell Viability Assays Market by Product 11.5.7.2.2 Argentina Cell Viability Assays Market by Cell Type 11.5.7.2.3 Argentina Cell Viability Assays Market by Application 11.5.7.2.4 Argentina Cell Viability Assays Market by End User 12. INDUSTRY LANDSCAPE 12.1. MERGERS AND ACQUISITIONS 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 12.3. NEW PRODUCT LAUNCHES 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS 13. CELL VIABILITY ASSAYS MARKET, KEY COMPANY PROFILES 13.1. THERMO FISHER SCIENTIFIC 13.1.1. Key Facts 13.1.2. Business Description 13.1.3. Products and Services 13.1.4. Financial Overview 13.1.5. SWOT Analysis 13.1.6. Key Developments 13.2. MERCK KGAA 13.2.1. Key Facts 13.2.2. Business Description 13.2.3. Products and Services 13.2.4. Financial Overview 13.2.5. SWOT Analysis 13.2.6. Key Developments 13.3. BIO-RAD LABORATORIES 13.3.1. Key Facts 13.3.2. Business Description 13.3.3. Products and Services 13.3.4. Financial Overview 13.3.5. SWOT Analysis 13.3.6. Key Developments 13.4. GE HEALTHCARE 13.4.1. Key Facts 13.4.2. Business Description 13.4.3. Products and Services 13.4.4. Financial Overview 13.4.5. SWOT Analysis 13.4.6. Key Developments 13.5. DANAHER CORPORATION 13.5.1. Key Facts 13.5.2. Business Description 13.5.3. Products and Services 13.5.4. Financial Overview 13.5.5. SWOT Analysis 13.5.6. Key Developments 13.6. BECTON, DICKINSON AND COMPANY 13.6.1. Key Facts 13.6.2. Business Description 13.6.3. Products and Services 13.6.4. Financial Overview 13.6.5. SWOT Analysis 13.6.6. Key Developments 13.7. PROMEGA CORPORATION 13.7.1. Key Facts 13.7.2. Business Description 13.7.3. Products and Services 13.7.4. Financial Overview 13.7.5. SWOT Analysis 13.7.6. Key Developments 13.8. ABCAM PLC 13.8.1. Key Facts 13.8.2. Business Description 13.8.3. Products and Services 13.8.4. Financial Overview 13.8.5. SWOT Analysis 13.8.6. Key Developments 13.9. PERKINELMER 13.9.1. Key Facts 13.9.2. Business Description 13.9.3. Products and Services 13.9.4. Financial Overview 13.9.5. SWOT Analysis 13.9.6. Key Developments 13.10. BIOTEK INSTRUMENTS 13.10.1. Key Facts 13.10.2. Business Description 13.10.3. Products and Services 13.10.4. Financial Overview 13.10.5. SWOT Analysis 13.10.6. Key Developments 14. APPENDIX 14.1. ABOUT THE INSIGHT PARTNERS 14.2. GLOSSARY OF TERMS
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.